Capstone (CAPS) Stock Price, News & Analysis

Company Overview

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Key Stats

• Today's Range: $1.80 to $1.95
• 50-Day Range: $1.66 to $2.90
• 52-Week Range: $1.58 to $16.18
• Volume: 24,375 shs
• Average Volume: 634,323 shs
• Market Capitalization: $300,200.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CAPS Stock Analysis - Frequently Asked Questions

How have CAPS shares performed this year?

Capstone's stock was trading at $2.40 at the beginning of 2025. Since then, CAPS shares have decreased by 20.8% and is now trading at $1.90.
View the best growth stocks for 2025 here.

When did Capstone IPO?

Capstone (CAPS) raised $5 million in an IPO on Thursday, March 6th 2025. The company issued 1,250,000 shares at a price of $4.00 per share.

When did the company's quiet period expire?

Capstone's quiet period expired on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During the company's quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Capstone?

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Pharmaceutical Preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:CAPS
• CIK: 887151
• Web: N/A
• Phone: (708) 371-0660
• Fax: N/A
• Employees: 38
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $43.42 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 158,000
• Free Float: N/A
• Market Cap: $297,830.00
• Optionable: N/A
• Beta: -0.82